Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
49.71
+1.46 (3.03%)
At close: Jun 26, 2026, 4:00 PM EDT
50.03
+0.32 (0.64%)
After-hours: Jun 26, 2026, 6:29 PM EDT
Structure Therapeutics Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Structure Therapeutics stock have an average target of 108.38, with a low estimate of 70 and a high estimate of 145. The average target predicts an increase of 118.02% from the current stock price of 49.71.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Structure Therapeutics stock from 16 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 12 | 11 | 11 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 16 | 17 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $100 → $70 | Buy | Reiterates | $100 → $70 | +40.82% | Jun 11, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 9, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $101 | Buy | Maintains | $101 | +103.18% | Jun 8, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 8, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $145 | Buy | Maintains | $145 | +191.69% | Jun 5, 2026 |
Financial Forecast
Revenue This Year
38.46M
Revenue Next Year
41.67K
from 38.46M
Decreased by -99.89%
EPS This Year
-1.29
from -1.42
EPS Next Year
-1.90
from -1.29
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 500.0M | 500,000 | |
| Avg | 38.5M | 41,670 | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | -98.7% | 2,120,015.2% |
| Avg | -99.9% | 335,514.5% |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.25 | -1.34 | |
| Avg | -1.29 | -1.90 | |
| Low | -1.93 | -3.08 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.